Skip to main content
Series / Collection

[MI] Coronavirus Shielded Patient List Summary Totals, England

Summary

This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience as open data to enable a broad base of users to perform analysis from it.

The purpose behind releasing this data is to present regional and local data to allow for its use in public health. It will also allow for greater analysis, modelling and planning to be performed using the latest data to aid in the response to the pandemic.

We will update this weekly and we would welcome your feedback to help us develop our open data sets.

The data that is published is based on the latest version of the SPL clinical algorithm at the time of data extraction. Please be aware that the SPL is continually being refreshed with additional, or updated data sources and/or updated logic.

This will impact the content of the SPL and therefore this publication is only accurate at the time of production and data should not be compared over time.

The open data files and dashboard contain the following analysis;

• A count of living patients that are classified as being on the Shielded Patient List by CCG of residence broken down by age band and gender

• A count of living patients that are classified as being on the Shielded Patient List by Local Authority of residence broken down by age band and gender

• A count of living patients that are classified as being on the Shielded Patient List by CCG of residence, broken down by disease group

• A count of living patients that are classified as being on the Shielded Patient List by Local Authority of residence, broken down by disease group

Data Caveats If a patient is added or deducted by both a GP and hospital, it is the latest request that is reported and this takes precedence over the algorithm.

A living patient is defined as any patient who does not have one or both of the informal and formal notification of death flags within the PDS data.

This analysis has exclusions at each level of geography meaning that the totals across CCG and Local Authority may not be the same and will not match the total number of patients.

CCG data only includes those patients who are resident in an English CCG. Non-English and invalid/unknown CCGs are excluded.

Local Authority data only include those patients who are resident in English local authorities. Non-English and invalid/unknown local authorities are excluded.

There are 13 disease groups as defined in the SPL clinical algorithm that have been signed off by the Chief Medical Officer (CMO). These disease groups are assigned to patients using the clinical algorithm but can also be assigned when a patient is added by a GP or hospital doctor.

Data cannot and should not be summed across disease groups. A patient can be in multiple disease groups therefore the number of patients on the list will not equal the sum of patients within each disease group.

In order to protect patient confidentiality '*' appears in the table above for all sub-national breakdowns, where it is possible to calculate a value between 1 and 7 from the data presented. All other sub-national data has been rounded to the nearest 5. For the purposes of disclosure control some local authorities have been combined to create larger areas, these are; - Cornwall and Isles of Scilly - Hackney and City of London

Further detail on data caveats are below;

Only Patients with an English CCG are included in this analysis and therefore the number of patients in the CCG data will not be the same as the total number of patients on the SPL. As the CCG is based on the postcode of the patient it is possible that the patients are interacting with services in England but resident in other countries outside of England i.e. Scotland, Wales and the Channel Islands. Whilst these patients are still included in the SPL they are excluded from this analysis.

Only Patients with an English Local Authority are included in this analysis and therefore the number of patients in the LA data will not be the same as the total number of patients on the SPL. LA is based on the postcode of the patient it is possible that the patients are interacting with services in England but resident in other countries outside of England i.e. Scotland, Wales and the Channel Islands. Whilst these patients are still included in the SPL they are excluded from this analysis.

Disease groups are those described within the SPL clinical algorithm that have been signed off by the Chief Medical Officer (CMO). There are 13 groups as detailed below;

Transplants (Solid), Cancer (Solid with Chemotherapy), Cancer (Lung with Radical Radiotherapy), Cancer (Haematological within 24 months), Transplants (Haematological within 6 months), Transplants (Haematological with Immunosuppression), Respiratory (Severe Asthma), Respiratory (Severe COPD), Respiratory (Severe Permanent), Corticosteroid Safety Card, Rare genetic metabolic and autoimmune diseases, Immunosuppression Therapy, Pregnant with Congenital Heart Defect.

Patients that are added by a GP or hospital can also be assigned to a disease group but this is not mandatory. As a patient can be in multiple disease groups the sum of patients within each disease group may not be the total number of patients of the SPL.

Latest Version

  • This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience as open data to enable a broad base of users to perform analysis from it.

Previous Versions

Resources